Investor Lists

Series C genomics investors

Updated 7 November 2026

Firms we have watched take part in a Series C round raised by a genomics company in the last two years. Both the stage and the sector are what they did, not what their website says.

See all 35 →The top 25
35investors on the listNo change this week
553cheques in 12 months+8% against the market
$111Mmedian round they joined+1288% against the market median
91%wrote a cheque in 12 months
57%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (24)

  1. 1Lightspeed Venture PartnersDeploying nowVC firm · United States1,341$35Mmedian roundNov 2026last seen
  2. 2Menlo VenturesDeploying nowVC firm · United States740$37Mmedian roundOct 2026last seen
  3. 3Qiming Venture PartnersDeploying nowVC firm · Hong Kong SAR China526$25Mmedian roundOct 2026last seen
  4. 4Founder CollectiveDeploying nowVC firm · United States502$8Mmedian roundSept 2026last seen
  5. 5Wellington ManagementDeploying nowVC firm · United States297$130Mmedian roundOct 2026last seen
  6. 6Hill House CapitalDeploying nowFamily office · Singapore248$60Mmedian roundSept 2026last seen
  7. 7Sofinnova InvestmentsDeploying nowVC firm · United States161$39Mmedian roundOct 2026last seen
  8. 8Hatteras Venture PartnersDeploying nowVC firm · United States104$20Mmedian roundNov 2026last seen
  9. 9MatrixDeploying nowHedge fund · United Arab Emirates104$31Mmedian roundNov 2026last seen
  10. 10nVenturesDeploying nowVC firm · Singapore97$26Mmedian roundJun 2026last seen
  11. 11Osage University PartnersDeploying nowVC firm · United States93$40Mmedian roundAug 2026last seen
  12. 12AlibabaDeploying nowGrowth equity · United States83$150Mmedian roundOct 2026last seen
  13. 13AbingworthDeploying nowVC firm · United Kingdom75$84Mmedian roundJul 2026last seen
  14. 14Eastern Bell CapitalDeploying nowPrivate equity · China72$15Mmedian roundJul 2026last seen
  15. 15Bain CapitalDeploying nowPrivate equity · United States58$50Mmedian roundAug 2026last seen
  16. 16Bain Capital Life SciencesDeploying nowPrivate equity · United States49$134Mmedian roundOct 2026last seen
  17. 17Lightstone VenturesquietVC firm · United States22$61Mmedian roundAug 2025last seen
  18. 18iGlobe PartnersDeploying nowVC firm · Singapore17$300Mmedian roundJul 2026last seen
  19. 19Mirae AssetDeploying nowVC firm · United States14$53Mmedian roundSept 2026last seen
  20. 20Ivy CapitalDeploying nowHedge fund · China9$249Mmedian roundJul 2026last seen
  21. 21HongShanDeploying nowVC firm5$103Mmedian roundJul 2026last seen
  22. 22TWG GlobalDeploying nowGrowth equity · United States4$425Mmedian roundApr 2026last seen
  23. 23Blue Focus PR ConsultingDeploying nowVC firm · China3$446Mmedian roundSept 2026last seen
  24. 24Korea EximbankDeploying nowGrowth equity · South Korea2$320Mmedian roundOct 2026last seen
  25. 25TemplewaterDeploying nowPrivate equity · Hong Kong SAR China2$111Mmedian roundJul 2026last seen
10 more on this list

All 35 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Reading for founders at Series B and scaling

More books for founders and investors on the Reading List.

As an Amazon Associate we earn from qualifying purchases.

Quick answers about series C genomics investors

Who are the most active series C genomics investors?

By cheques observed, the most active are Lightspeed Venture Partners, Menlo Ventures, Qiming Venture Partners, Founder Collective and Wellington Management.

How many series C genomics investors are there?

35 are on record. 91% made an investment in the last 12 months and 57% have led a round.

Which stages do series C genomics investors back?

Of the rounds with a named stage in the last 12 months, mostly Series A (26%) and Series B (18%).

How big are the rounds series C genomics investors join?

The typical (median) round among the leading investors here is $60M.

Which sectors do series C genomics investors back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which series C genomics investors lead the most rounds?

Lightspeed Venture Partners (83 led), Menlo Ventures (39 led) and Wellington Management (15 led).

Where are series C genomics investors based?

Among the most active, most are based in the United States (13), Singapore (3) and China (3).

What have series C genomics investors invested in recently?

Recent rounds include Specific Biologics (Series A, Nov 2026, with Hatteras Venture Partners), Hypersonica (Series B, Nov 2026, with Lightspeed Venture Partners) and General Medicine (Series B, Nov 2026, with Matrix).

Built from the rounds we watched, refreshed every night. How we count · Report a correction